Gene · 51203
Papers1,551
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,551
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IC2Bert: masked gene expression pretraining and supervised fine tuning for robust immune checkpoint blockade (ICB) response prediction. | Sci Rep | 2025 | 40745034 | PubTator, text mining | PubMed |
| Engineered lipid nanoparticles with synergistic dendritic cell targeting and enhanced endosomal escape for boosted mRNA cancer vaccines. | Mater Today Bio | 2025 | 40740252 | PubTator, text mining | PubMed |
| Sequence simplification of antigen coding IVT mRNA allows accelerated synthetic DNA template generation and epitope immunogenicity validation. | Mol Ther Nucleic Acids | 2025 | 40673161 | PubTator, text mining | PubMed |
| The role and therapeutic value of NUSAP1 in human cancers. | J Transl Med | 2025 | 40605080 | PubTator, text mining | PubMed |
| Research progress on NUSAP1 and its role in digestive system neoplasms. | Front Oncol | 2025 | 40535133 | PubTator, text mining | PubMed |
| In Silico Analysis Revealed a Role for NUSAP1 in Lung Adenocarcinoma through E2F1/hsa-let-7b-5p/lncRNA-TMPO-AS1. | Asian Pac J Cancer Prev | 2025 | 40439393 | PubTator, text mining | PubMed |
| PRMT1-catalyzed NUSAP1 methylation enhances Notch2 signaling and 5-FU resistance in gastric cancer. | Cell Death Dis | 2025 | 40393971 | PubTator, text mining | PubMed |
Identification of key biomarker genes in liver hepatocellular carcinoma and kidney renal clear cell carcinoma progression: A shared high-throughput screening and molecular docking method with potentials for targeted therapeutic interventions. | J Genet Eng Biotechnol | 2025 | 40390492 | PubTator, text mining | PubMed |
| mRNAdesigner: an integrated web server for optimizing mRNA design and protein translation in eukaryotes. | Nucleic Acids Res | 2025 | 40384581 | PubTator, text mining | PubMed |
| HBV core protein enhances WDR46 stabilization to upregulate NUSAP1 and promote HCC progression. | Hepatol Commun | 2025 | 40366140 | PubTator, text mining | PubMed |
| RAD51 expression and prognostic impact in patients with stomach adenocarcinoma. | PeerJ | 2025 | 40231067 | PubTator, text mining | PubMed |
| Proceedings of the 15th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals. | MAbs | 2025 | 40181240 | PubTator, text mining | PubMed |
| Pyruvate metabolism enzyme DLAT promotes tumorigenesis by suppressing leucine catabolism. | Cell Metab | 2025 | 40112809 | PubTator, text mining | PubMed |
| The Role of PLIN3 in Prognosis and Tumor-Associated Macrophage Infiltration: A Pan-Cancer Analysis. | J Inflamm Res | 2025 | 40098998 | PubTator, text mining | PubMed |
| Developing a gene expression classifier for breast cancer diagnosis. | Med Biol Eng Comput | 2025 | 40080330 | PubTator, text mining | PubMed |
| Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines. | Signal Transduct Target Ther | 2025 | 40059188 | PubTator, text mining | PubMed |
| High NUSAP1 expression predicts poor survival in laryngeal squamous cell carcinoma. | Indian J Pathol Microbiol | 2025 | 39980241 | PubTator, text mining | PubMed |
| Developing mRNA Nanomedicines with Advanced Targeting Functions. | Nanomicro Lett | 2025 | 39979495 | PubTator, text mining | PubMed |
| Single-cell sequencing elucidates the mechanism of NUSAP1 in glioma and its diagnostic and prognostic significance. | Front Immunol | 2025 | 39975552 | PubTator, text mining | PubMed |
| iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA. | NPJ Vaccines | 2025 | 39971939 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51203/papers?page=5